George Demuth, MS
Chief Executive Officer
George serves in a leadership role with the company, as well as lead-statistician for client studies. He has worked in the industry for over 30 years and has experience with pharmaceutical, biotech and medical device studies. During his career he has worked with hundreds of clients and helped obtain approval for products from a broad range of therapeutic areas. George has represented clients in FDA meetings including panel presentations. He has served as the lead statistician or team leader on products cleared or approved in all areas of the FDA (PMAs, 510(k)s, NDAs, and BLAs). His broad range of statistical analysis experience includes DMC/DSMBs, analysis planning, interim analyses, adaptive trials, and other areas. George has also been the primary developer of proprietary company software, reporting systems and programming tools to help improve efficiency and appearance of output.